| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology and Visual Sciences and 2 Microbiology, The Chinese University of Hong Kong, Hong Kong, China.
PURPOSE. To investigate the precipitation process of a mixture of vancomycin and ceftazidime by equilibrium dialysis and determine its subsequent effect on the level of free antibiotics for treatment of endophthalmitis.
METHODS. Concentrations of vancomycin and ceftazidime in an equilibrium dialysis chamber were measured during the equilibrium process by high-performance liquid chromatography. Normal saline (NS), balanced salt solution (BSS), and vitreous were used separately as the medium of dialysis.
RESULTS. Precipitation of ceftazidime occurred at 37°C but not at room temperature and did not affect the pH of the medium. It formed precipitate on its own or when mixed with vancomycin in all the three media of NS, BSS, and vitreous. More precipitation was formed if ceftazidime was initially prepared in BSS than in NS. After 168 hours in the dialysis chambers, ceftazidime prepared in NS precipitated to 54% of that in vitreous, compared with 88% if prepared in BSS. At 48 hours, ceftazidime prepared in NS decreased from an initial concentration of 137.5 to 73.4 µg/mL in vitreous medium and to 6.3 µg/mL if prepared in BSS. Precipitation of vancomycin was negligible.
CONCLUSIONS. Based on this in vitro investigation, ceftazidime precipitates in vitreous at body temperature, regardless of the presence of vancomycin. NS is preferred to BSS as a preparation medium for antibiotics for intravitreal injection, because the extent of ceftazidime precipitation is less. However, due to precipitation, the concentration of free ceftazidime in vitreous may not be sufficiently high for antibacterial activity against most common organisms.
This article has been cited by other articles:
|
|
 |
|
  K.-J. Chen, T.-L. Chen, C.-C. Lai, and M.-H. Sun Endophthalmitis: Antibacterial Activity of Precipitates of Vancomycin and Ceftazidime J. Clin. Microbiol., June 1, 2008; 46(6): 2149 - 2149. [Full Text] [PDF]
|
|
|
|
|
|
M. Hui, W. H. Lam, W. H. Ho, and C. Y. Chan Endophthalmitis: Potential Benefits of Repeated Intravitreal Injections of Antibiotics J. Clin. Microbiol., April 1, 2008; 46(4): 1573 - 1573. [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Doft Treatment of Postcataract Extraction Endophthalmitis: A Summary of the Results From the Endophthalmitis Vitrectomy Study Arch Ophthalmol, April 1, 2008; 126(4): 554 - 556. [Full Text] [PDF]
|
|
|
|
 |
|
 V Vedantham Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin! Br. J. Ophthalmol., February 1, 2005; 89(2): 249 - 250. [Full Text] [PDF]
|
|
|
|
|
|
G D Galloway, A Ramsay, K Jordan, and A Vivian Macular infarction after intravitreal amikacin: authors' reply Br. J. Ophthalmol., September 1, 2004; 88(9): 1228 - 1228. [Full Text] [PDF]
|
|
|
|
|
|
B H Doft and M Barza Macular infarction after intravitreal amikacin Br. J. Ophthalmol., June 1, 2004; 88(6): 850 - 850. [Full Text] [PDF]
|
|
|
|
|
|
M Hui, A K H Kwok, C P Pang, S W Cheung, R C Y Chan, D S C Lam, and A F B Cheng An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous Br. J. Ophthalmol., February 1, 2004; 88(2): 218 - 222. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
